GangaGen
PrivateLast Round
Grant
Oct 4, 2020
Total Funding Raised
$19.4M
Company Overview
GangaGen is a biotechnology company that specializes in the discovery and development of novel therapeutic proteins and phages for the treatment of serious bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GangaGen Comparables
Compare GangaGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Locus Biosciences | 83% | |
| Telum Therapeutics | 79% | |
| Micreos | 78% | |
GangaGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 4, 2020 | ||||
| Series E | Dec 1, 2008 | ||||
| Seed | Jun 1, 2001 |
GangaGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| ATEL Ventures | Series E |
GangaGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GangaGen's valuation, stock price, and market status.